Literature DB >> 18209073

Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus.

Michelle Roti1, Junbao Yang, DeAnna Berger, Laurie Huston, Eddie A James, William W Kwok.   

Abstract

It is commonly perceived that the human immune system is naive to the newly emerged H5N1 virus. In contrast, most adults have been exposed to influenza A H1N1 and H3N2 viruses through vaccination or infection. Adults born before 1968 have likely been exposed to H2N2 viruses. We hypothesized that CD4(+) T cells generated in response to H1N1, H3N2, and H2N2 influenza A viruses also recognize H5N1 epitopes. Tetramer-guided epitope mapping and Ag-specific class II tetramers were used to identify H5N1-specific T cell epitopes and detect H5N1-specific T cell responses. Fifteen of 15 healthy subjects tested had robust CD4(+) T cell responses against matrix protein, nucleoprotein, and neuraminidase of the influenza A/Viet Nam/1203/2004 (H5N1) virus. These results are not surprising, because the matrix protein and nucleoprotein of influenza A viruses are conserved while the neuraminidase of the H5N1 virus is of the same subtype as that of the circulating H1N1 influenza strain. However, H5N1 hemagglutinin-reactive CD4(+) T cells were also detected in 14 of 14 subjects examined despite the fact that hemagglutinin is less conserved. Most were cross-reactive to H1, H2, or H3 hemagglutinin epitopes. H5N1-reactive T cells were also detected ex vivo, exhibited a memory phenotype, and were capable of secreting IFN-gamma, TNF-alpha, IL-5, and IL-13. These data demonstrate the presence of H5N1 cross-reactive T cells in healthy Caucasian subjects, implying that exposure to influenza A H1N1, H3N2, or H2N2 viruses through either vaccination or infection may provide partial immunity to the H5N1 virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209073      PMCID: PMC3373268          DOI: 10.4049/jimmunol.180.3.1758

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens.

Authors:  E J Novak; A W Liu; J A Gebe; B A Falk; G T Nepom; D M Koelle; W W Kwok
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining.

Authors:  Thomas J Scriba; Marco Purbhoo; Cheryl L Day; Nicola Robinson; Sarah Fidler; Julie Fox; Jonathan N Weber; Paul Klenerman; Andrew K Sewell; Rodney E Phillips
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 4.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

5.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

Authors:  Suzanne L Epstein
Journal:  J Infect Dis       Date:  2005-11-21       Impact factor: 5.226

6.  Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals.

Authors:  Taronna R Maines; Xui Hua Lu; Steven M Erb; Lindsay Edwards; Jeannette Guarner; Patricia W Greer; Doan C Nguyen; Kristy J Szretter; Li-Mei Chen; Pranee Thawatsupha; Malinee Chittaganpitch; Sunthareeya Waicharoen; Diep T Nguyen; Tung Nguyen; Hanh H T Nguyen; Jae-Hong Kim; Long T Hoang; Chun Kang; Lien S Phuong; Wilina Lim; Sherif Zaki; Ruben O Donis; Nancy J Cox; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies.

Authors:  Krystyna Mozdzanowska; Michelle Furchner; Darya Zharikova; Jingqi Feng; Walter Gerhard
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.

Authors:  Ron A M Fouchier; Vincent Munster; Anders Wallensten; Theo M Bestebroer; Sander Herfst; Derek Smith; Guus F Rimmelzwaan; Björn Olsen; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 9.  Avian influenza A (H5N1).

Authors:  Menno D de Jong; Tran Tinh Hien
Journal:  J Clin Virol       Date:  2005-10-06       Impact factor: 3.168

Review 10.  Avian influenza virus infections in humans.

Authors:  Samson S Y Wong; Kwok-Yung Yuen
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

View more
  75 in total

1.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

Review 3.  Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.

Authors:  Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

4.  Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain.

Authors:  John M Barry; Cécile Viboud; Lone Simonsen
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

5.  Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.

Authors:  T V Chirkova; A N Naykhin; G D Petukhova; D A Korenkov; S A Donina; A N Mironov; L G Rudenko
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

6.  Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.

Authors:  Eddie A James; Rebecca E LaFond; Theresa J Gates; Duy T Mai; Uma Malhotra; William W Kwok
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

7.  H5N1 strain-specific hemagglutinin CD4+ T cell epitopes restricted by HLA DR4.

Authors:  Junbao Yang; John A Gebe; Laurie Huston; Eddie James; Venus Tan; Betty B Yue; Gerald T Nepom; William W Kwok
Journal:  Vaccine       Date:  2009-05-03       Impact factor: 3.641

8.  CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination.

Authors:  Junbao Yang; Eddie James; Theresa J Gates; Jonathan H DeLong; Rebecca E LaFond; Uma Malhotra; William W Kwok
Journal:  Int Immunol       Date:  2013-03-22       Impact factor: 4.823

9.  Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals.

Authors:  Junbao Yang; Eddie James; Michelle Roti; Laurie Huston; John A Gebe; William W Kwok
Journal:  Int Immunol       Date:  2008-12-02       Impact factor: 4.823

10.  Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.

Authors:  Hamid R Haghighi; Leah R Read; S M Mansour Haeryfar; Shahriar Behboudi; Shayan Sharif
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.